BEAM THERAPEUTICS INCBEAM THERAPEUTICS INCBEAM THERAPEUTICS INC

BEAM THERAPEUTICS INC

No trades
See on Supercharts

Key facts today

Beam Therapeutics Inc. reported a Q3 2024 net loss of $1.17 per share, an improvement from last year's $1.22. Revenue fell to $14.3 million, with $925.8 million in cash available until 2027.
Analyze the impactAnalyze the impact
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪40.41 B‬MXN
−32.35MXN
‪−2.25 B‬MXN
‪6.42 B‬MXN
‪71.66 M‬
Beta (1Y)
2.19
Employees (FY)
436
Change (1Y)
−71 −14.00%
Revenue / Employee (1Y)
‪866.31 K‬MXN
Net income / Employee (1Y)
‪−303.96 K‬MXN

About Beam Therapeutics Inc.


CEO
John Evans
Website
Headquarters
Cambridge
Founded
2017
FIGI
BBG0166VGZN0
Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange BEAM THERAPEUTICS INC stocks are traded under the ticker BEAM.
BEAM stock has risen by 5.47% compared to the previous week, the month change is a 5.47% rise, over the last year BEAM THERAPEUTICS INC has showed a 11.79% increase.
We've gathered analysts' opinions on BEAM THERAPEUTICS INC future price: according to them, BEAM price has a max estimate of 1,610.31 MXN and a min estimate of 462.96 MXN. Watch BEAM chart and read a more detailed BEAM THERAPEUTICS INC stock forecast: see what analysts think of BEAM THERAPEUTICS INC and suggest that you do with its stocks.
BEAM stock is 5.68% volatile and has beta coefficient of 2.19. Track BEAM THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is BEAM THERAPEUTICS INC there?
Today BEAM THERAPEUTICS INC has the market capitalization of ‪40.41 B‬, it has increased by 3.72% over the last week.
Yes, you can track BEAM THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
BEAM THERAPEUTICS INC is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
BEAM earnings for the last quarter are −23.05 MXN per share, whereas the estimation was −23.31 MXN resulting in a 1.12% surprise. The estimated earnings for the next quarter are −24.97 MXN per share. See more details about BEAM THERAPEUTICS INC earnings.
BEAM THERAPEUTICS INC revenue for the last quarter amounts to ‪281.15 M‬ MXN, despite the estimated figure of ‪286.00 M‬ MXN. In the next quarter, revenue is expected to reach ‪336.35 M‬ MXN.
BEAM net income for the last quarter is ‪−1.90 B‬ MXN, while the quarter before that showed ‪−1.67 B‬ MXN of net income which accounts for −14.05% change. Track more BEAM THERAPEUTICS INC financial stats to get the full picture.
No, BEAM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 6, 2024, the company has 436.00 employees. See our rating of the largest employees — is BEAM THERAPEUTICS INC on this list?
Like other stocks, BEAM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BEAM THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.